Results 121 to 130 of about 8,118 (201)

Long-term outcomes of Graves' disease in children and adolescents receiving antithyroid drugs. [PDF]

open access: yesAnn Pediatr Endocrinol Metab, 2021
Rho JG   +5 more
europepmc   +1 more source

The role of selenium in autoimmune thyroiditis

open access: yesJournal of Biological Research
Selenium (Se) is an essential trace element of fundamental importance for human health. Se is incorporated into selenoproteins (SPs) which are endowed with pleiotropic effects including antioxidant and anti-inflammatory effects and active production of ...
Marco Giammanco   +3 more
doaj   +1 more source

Audit of long-term treatment outcomes of thyrotoxicosis in a single-centre virtual clinic: The utility of long-term antithyroid drugs. [PDF]

open access: yesClin Endocrinol (Oxf), 2022
Levy MJ   +9 more
europepmc   +1 more source

Individualized Graves' disease remission rates conversations: a videographic analysis of medical encounters. [PDF]

open access: yesEndocrine, 2022
Hidalgo J   +5 more
europepmc   +1 more source

Dose-Dependent Influence of Antithyroid Drugs on the Difference in Free Thyroxine Levels between Mothers with Graves' Hyperthyroidism and Their Neonates. [PDF]

open access: yesEur Thyroid J, 2021
Iwaki H   +10 more
europepmc   +1 more source

Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves`disease

open access: yes, 2004
Ziel vorliegender Studie war die Einflussfaktoren der Radioiodtherapie bei der Autoimmunthyreopathie vom Typ M. Basedow insbesondere im Hinblick auf die prätherapeutische thyreostatische Therapie aufgrund der unklaren Datenlage zu erfassen.
Kleinert, Kathrin
core  

Efficacy of radioactive iodine therapy with concomitant antithyroid drugs in Japanese patients with Graves' disease: a retrospective observational study. [PDF]

open access: yesBMC Res Notes
Osaki Y   +9 more
europepmc   +1 more source

Rethinking antithyroid drugs in pregnancy

open access: yes
Uncontrolled hyperthyroidism in pregnancy poses a risk to both mother and foetus, and the optimal treatment strategy in this setting remains elusive. Instigation of pharmacological therapy or an alternative intervention during pregnancy requires careful ...
Napier C, Pearce SHS
core  

The use of antithyroid drugs should be reduced as much as possible in the first trimester.

open access: yes, 2014
The treatment of choice for hyperthyroidism in pregnancy is antithyroid drugs, but the potential risk of birth defects is of major concern. For the use of thiamazole and carbimazole, there is consistent evidence of an increased risk of birth defects ...
Laurberg, Peter   +1 more
core  

Home - About - Disclaimer - Privacy